Sutter Health receives $30 million donation for cancer center in Santa Cruz
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
17 minutes ago
- Yahoo
The spice linked to low blood sugar and gum disease prevention
HOLD FOR PUB UNTIL FRI Cloves can do much more than just sweeten your baked goods. Used for thousands of years in traditional medicine, the warm spice commonly used in pumpkin pie and mulled wine may also benefit your gum health and lower your blood pressure, according to years of research. 'The antibacterial properties of cloves help kill harmful bacteria inside your mouth,' Idaho's Summit Dental Group explains. 'This makes cloves highly effective in controlling plaque and reducing the risk of gum disease.' Clove oil serves as a natural antimicrobial substance, stopping the growth of bacteria and fungi, according to studies. Just a few drops are enough. People shouldn't add more than 10 to 15 drops in an ounce of water, according to the National Association for Holistic Aromatherapy. Clove oil can be an irritant for some people, particularly on the skin. This is because cloves contain eugenol, a yellow-colored compound commonly found in cinnamon and bay leaves. Eugenol affects the our ability to stop bleeding, according to the Cleveland Clinic. It can be harmful when adults take as little as 10 milliliters of eugenol, according to Mount Sinai. Children should not consume it. Still, eugenol is generally safe in the quantities found in food products made with ground cloves. Most pumpkin pie recipes don't call for more than a teaspoon of the spice. Eugenol has the ability to kill yeast, which can be the result of an overgrowth of fungus in the mouth. The compound is also what researchers say can lower your blood sugar levels. After taking 250 milligrams of clove extract daily for 30 days, researchers said participants in a 2019 study had significantly lower blood sugar after meals. Cloves are also packed with essential minerals. The spice has calcium to maintain strong bones, magnesium that can regulate blood sugar and calcium levels, potassium that helps the nerves and supports heart health, and vitamin K, which helps keep arteries healthy. Eugenol may help improve bone mass as well, according to research on animals. Lastly, cloves are a natural antioxidant, the substances found in foods that can prevent damage to cells and DNA. Experts say people need a variety of antioxidant-rich foods each day, such as berries and nuts. 'Antioxidants are almost like a shield around your cells, like a blanket around them to protect them from oxidative damage,' registered dietitian Julia Zumpano explained to the Cleveland Clinic.
Yahoo
17 minutes ago
- Yahoo
Epigenetics Market worth US$4.29 billion in 2030 with 13.9% CAGR
DELRAY BEACH, Fla., Aug. 15, 2025 /PRNewswire/ -- The global Epigenetics Market, valued at US$2.03 billion in 2024, stood at US$2.24 billion in 2025 and is projected to advance at a resilient CAGR of 13.9% from 2025 to 2030, culminating in a forecasted valuation of US$4.29 billion by the end of the period. The major factors driving the growth in the flow cytometry market include advancements in technology, increasing adoption of flow cytometry products in clinical diagnostics, rising prevalence of chronic diseases, growing biopharmaceutical R&D, and the need for precision medicine. The significant rise in oncology research has increased the demand for flow cytometry products and services. Additionally, the integration of AI and machine learning is enhancing data analysis capabilities, further fueling market growth. Download PDF Brochure: Browse in-depth TOC on "Epigenetics Market" 365 - Tables45 - Figures353 - Pages By offering, the global epigenetics market is segmented into various categories, including kits and reagents, enzymes, instruments and accessories, software, and services. Within the kits and reagents category, there are sub-segments such as antibodies, chip-sequencing kits and reagents, bisulfite conversion kits and reagents, whole-genome amplification kits and reagents, 5-HMC and 5-MC analysis kits and reagents, histones, as well as other kits and reagents. In 2024, the Antibodies segment is projected to command the largest market share. This is attributed to the increasing reliance on antibodies for the detection, identification, and modification of proteins, along with their essential function in monitoring cellular regulation and gene expression. Consequently, the growth of the antibodies segment is expected to accelerate throughout the forecast period due to these advancements. By Method, the epigenetics market segmentation by methodology includes DNA methylation, histone modifications, and additional approaches such as non-coding RNA interactions and chromatin remodeling. The DNA methylation segment is projected to exhibit a robust compound annual growth rate (CAGR) throughout the forecast period, primarily driven by its proven effectiveness in oncology research applications. By geography, The Asia Pacific region is projected to experience the most rapid growth within the epigenetics market. This expansion is driven by the increasing global footprint of local companies through strategic alliances and collaborations, alongside continuous enhancements in healthcare infrastructure in emerging economies. Moreover, there is a heightened emphasis on advancing capabilities in Next-Generation Sequencing (NGS), which is further propelling market development in the region. Request Sample Pages : Key players in the epigenetics market include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Illumina, Inc. (US), PacBio (US), Danaher (US), Active Motif, Inc. (US), Bio-Rad Laboratories, Inc. (US), Promega Corporation (US), Revvity (US), QIAGEN (Germany), among others. Illumina Inc (US): In 2024, Illumina, Inc. maintained a preeminent position in the genomics market, capitalizing on a well-established customer base that includes leading pharmaceutical and biotechnology companies, genomic research institutions, and various government laboratories and hospitals. The firm possesses a dominant market share in the next-generation sequencing (NGS) domain, which affords it a competitive edge when exploring adjacent sectors, such as epigenetic sequencing. A notable move in this direction occurred in June 2025, when Illumina announced its acquisition of SomaLogic. This strategic acquisition is poised to bolster Illumina's footprint in the burgeoning epigenetics market and further its multiomics strategy, integrating diverse biological data for enhanced insights into genomics, transcriptomics, proteomics, and epigenomics. Thermofisher Scientific Inc. (US) Thermo Fisher Scientific Inc. (US) stands out as a prominent player in the epigenetics market in 2024, driven by a robust and diversified product portfolio, an extensive global footprint, and a strategic focus on both organic and inorganic growth initiatives. Notably, in July 2025, the company secured US Food and Drug Administration (FDA) approval for the Oncomine Dx Express Test, utilizing the Ion Torrent Genexus Dx Integrated Sequencer as an in vitro diagnostic (IVD) assay designed for companion diagnostics (CDx) in tumor profiling applications. Thermo Fisher demonstrates a strong commitment to research and development, channeling significant resources into innovation to address the dynamic needs of its clientele. Their comprehensive global distribution network enhances accessibility and customer support, facilitating the delivery of advanced and reliable epigenetics solutions. This multifaceted strategic approach solidifies Thermo Fisher's position as a leading provider in the epigenetics landscape. For more information, Inquire Now! Related Reports: Research Antibodies & Reagents Market Genomics Market Next Generation Sequencing Market PCR Technologies Market Digital PCR and qPCR Market Get access to the latest updates on Epigenetics Companies and Epigenetics Market Size About MarketsandMarkets™: MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter, LinkedIn and Facebook. Contact:Mr. Rohan SalgarkarMarketsandMarkets™ INC.1615 South Congress 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: sales@ Our Website: Logo: View original content: SOURCE MarketsandMarkets Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
17 minutes ago
- Yahoo
FluMist, a vaccine nasal spray, is now available for use at home
Those looking to protect themselves against the flu this season now have an at-home option. FluMist, the only nasal spray flu vaccine approved by the Food and Drug Administration, is now available for purchase for self-administration. AstraZenca's FluMist was approved in 2003 to be given by health care providers. Last year, the FDA broadened the approval of the nasal spray to make it the first self-administered option. An at-home delivery service, called FluMist Home, will be available in 34 states this flu season. Through FluMist Home, customers can get the same FluMist nasal spray — shipped to their homes — that patients can receive at a doctor's office or pharmacy. How much does FluMist cost? According to the online ordering platform, FluMist is free under most commercial insurance. There is, however, a fee of $8.99 for shipping and processing. To order, customers have to give some basic personal information, medical details, insurance information and a payment method. Who can use FluMist at home? FluMist is approved for at-home use for those ages 2 to 49, but a caregiver should administer FluMist to individuals 2 through 17, according to the website. The website includes instructions on how to administer the spray to yourself and family members. FluMist should not be used in people with "a severe allergy to its components, eggs or other flu vaccines," according to the product's website, which offers a full list of patient and safety information. What states is FluMist Home available in? According to a news release, FluMist Home will be available in the following states for the 2025-2026 flu season: AlabamaArizonaCaliforniaColoradoConnecticutFloridaGeorgiaIowaIdahoIllinoisMassachusettsMarylandMaineMichiganMontanaNorth CarolinaNorth DakotaNebraskaNew HampshireNew JerseyNevadaOhioOregonPennsylvaniaSouth CarolinaSouth DakotaTennesseeTexasUtahVirginiaVermontWashingtonWisconsinWyoming "There are a number of states where FluMist Home is unavailable due to local pharmacy laws," the release notes. "Our aim is to have this service available in all 48 contiguous states in future seasons." Passenger arrested after allegedly causing disturbance midair and forcing flight to divert When could Tropical Storm Erin become a hurricane? Urban garden helps combat food insecurity in Miami Solve the daily Crossword
